Latest filing published 01 Oct 2020 for Nabriva Therapeutics plc, €166.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Francesco Maria Lavino: trading record in brief
This profile gathers the share dealings of Francesco Maria Lavino in Nabriva Therapeutics plc. Over a trading history stretching from 29 November 2017 to 30 September 2020, the count stands at 18 filings.
Market trades split into 3 purchases (€26k) and 1 sale (€7,121). Netting one side against the other leaves €19k of net buying. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 12 share grants and 2 option exercises.
Half of the purchases are above €8,485 and half below. Of 3 purchases, 1 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
The latest filing, published on 1 October 2020, reports a share grant of €166 in Nabriva Therapeutics plc. The most recent open-market purchase was published on 26 August 2019, 2,632 days ago. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Francesco Maria Lavino
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 366 shares@ US$0.5331.9% of flowOrdinary SharesSEC:0001104659-20-111076:0
- 366 shares@ US$0.61942.2% of flowOrdinary SharesSEC:0001104659-20-101907:0
- 11,250 sharesOrdinary SharesSEC:0001104659-20-097719:0
- 3,759 shares@ US$0.647623.2% of flowOrdinary SharesSEC:0001104659-20-097719:1
- 366 shares@ US$0.762.7% of flowOrdinary SharesSEC:0001104659-20-090283:0
- 366 shares@ US$0.67462.5% of flowOrdinary SharesSEC:0001104659-20-080542:0
- 366 shares@ US$1.144.3% of flowOrdinary SharesSEC:0001104659-20-069179:0
- 366 shares@ US$0.54832.1% of flowOrdinary SharesSEC:0001104659-20-056348:0
- 366 shares@ US$0.5752.2% of flowOrdinary SharesSEC:0001104659-20-042581:0
- 366 shares@ US$1.351.4% of flowOrdinary SharesSEC:0001104659-20-028848:0
- 105,000 shares0Ordinary SharesSEC:0001104659-20-015173:0
- 3,892 shares@ US$1.3519.2% of flowOrdinary SharesSEC:0001104659-20-010899:0
- 4,800 shares@ US$2.0435.7% of flowOrdinary SharesSEC:0001104659-19-047352:0Canonical exit: 20 Nov 2019 (T+90)
- 11,250 sharesOrdinary SharesSEC:0001104659-19-046855:0
- 3,797 shares@ US$2.0828.7% of flowOrdinary SharesSEC:0001104659-19-046855:1
- 2,160 shares@ US$4.6020.4% of flowOrdinary SharesSEC:0001104659-18-036324:0Canonical exit: 21 Aug 2018 (T+90)
- 1,569 shares@ US$6.2920.0% of flowOrdinary SharesSEC:0001104659-17-071439:0Canonical exit: 27 Feb 2018 (T+90)
17 of 17 declarations